Market Overview

Omnicare Announces Agreement with DEA

Share:

Omnicare, Inc. (NYSE: OCR) today announced a civil settlement with the United States Department of Justice relating to a previously-disclosed investigation by the Drug Enforcement Administration ("DEA") of alleged errors and deficiencies in dispensing controlled substances by certain Omnicare pharmacies.

Pursuant to this civil settlement, Omnicare will pay the government $50 million. The settlement releases Omnicare's wholly-owned and joint venture long-term care pharmacies from all civil penalty claims by the DEA related to the subject matter of the investigation. The settlement announced today has been fully reserved. The settlement contains no allegation or finding that any controlled substances were unlawfully diverted from the intended patient or that any patient was harmed.

Posted-In: News Legal

 

Related Articles (OCR)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→